Menu
Focal One combines the latest imaging and high-intensity focused ultrasound (HIFU) technology to precisely contour and ablate the targeted lesion while avoiding critical structures.
The Focal One® HIFU Robotic System uses high-performance imaging, and HIFU technology allows the Urologist to precisely target the prostate with submillimetric accuracy while sparing healthy surrounding tissue and preserving patients’ quality of life.
HIFU technology ablates prostate tissue by focusing high-intensity ultrasound waves on the affected area, causing localized heating that destroys the cells in the gland without damaging the healthy surrounding tissue. Focused ultrasound works in the same way as rays of sunlight that pass through a magnifying glass and are concentrated at a single point, equally causing a significant temperature rise around the focal point.
The whole prostate is scanned by the transrectal ultrasound imaging probe and displayed on the Focal One screen as a three-dimensional reconstruction of the area to be ablated.
On the screen, the urologist plans each step of the procedure, precisely targeting the area to be ablated.
Finally, the system automatically determines the optimal number of lesions based on the planning and produces High Intensity Focused Ultrasound waves to destroy the targeted cells.
What happens after the procedure?
At the end of the procedure, a temporary urinary catheter will be placed in order to limit the risk of urinary retention due to the temporary swelling. This catheter can be removed at the first follow-up visit. Typical follow-up will include PSA testing at three months, six months, and one year, to evaluate the result. This follow-up can be performed by the treating urologist, or, if you traveled from a remote location, your local urologist.
A large body of clinical evidence shows promising cancer control. Watch Dr. Lance Willsey discuss the benefits of targeted, precise Prostate ablation with HIFU which can offer the best outcomes for both Physician and Patient. HIFU allows the Physician to preserve a Patient’s quality of life. Patients maintain their continence and preservation of sexual function following HIFU treatment.
DAYTONA BEACH, Fla. (22 January 2024) – Sean Creech Motorsport (SCM) came out of the box strong at last weekend’s Roar Before the Rolex 24, showing consistent improvement with the reintroduced Ligier JS P217 as the team prepares for its IMSA WeatherTech SportsCar Championship LMP2 class debut at the Rolex 24 at Daytona (NBC/USA/Peacock, 1:40 p.m. Saturday-Sunday).